← Open Payments lookup

CHERYL GISTAND: Open Payments

NPI 1922560440 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$269 in 13 payments from 10 companies in 2025. Trend: 2023 $164 · 2024 $190 · 2025 $269

Food & beverage: $269
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.3$51
Axsome Therapeutics, Inc.1$35
Otsuka America Pharmaceutical, Inc.2$34
Biogen, Inc.1$29
Teva Pharmaceuticals USA, Inc.1$25
Neurocrine BioSciences, Inc.1$21
Indivior Inc.1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Janssen Pharmaceuticals, Inc1$20
Alkermes, Inc.1$14

Products named: FANAPT, Auvelity, ZURZUVAE, AUSTEDO XR, INGREZZA, SUBLOCADE, CAPLYTA, INVEGA SUSTENNA.

Industry payments across IN — which companies pay providers there.